Who Will You Be Joining?

Here's a small sample of the attendees:

Clinical Trial Manager, Insmed

Senior Clinical Trial Associate, Insmed Incorporated

Clinical Trial Manager, Insmed

Quality Audit Management, BioNTech

Senior Project Manager, Prometrika

Senior Project Manager, Prometrika

Sr. Director, Clinical Project Management, Zenas BioPharma

Lead Research Nurse, Guys and St Thomas NHS Foundation Trust

Director, Program Management, Perspective Therapeutics

Sr. Director, Site Services, CTI Clinical Research Center

Director, Astellas

Clinical Research Specialist, Merck Animal Health

Senior Director & Head of Clinical Operations, Tris Pharma, Inc.

Director, Statistical Programming, Esperion Therapeutics

Director, Real World Value & Evidence (Oncology), Johnson & Johnson

Vice President, Eir Partners

Director, Country Operations Management, Pfizer

Sr. Manager, Clinical Research, Sight Sciences, Inc.

Investor, Eir Partners

Sr. Program Manager, Clinical Program Quality, Takeda

Clinical Research Coordinator, Minneapolis Heart Institute Foundation

Head, GI² Clinical Program Quality, Takeda

Senior Manager, Process Excellence and Delivery, Takeda Pharmaceuticals

Research Assistant, Genetics, North York General Hospital

Director, Quality Science and Technology, AstraZeneca

SVP of Global Clinical Operations, ILIAD Biotechnologies

Clinical Operations Executive Director, ILIAD Biotechnologies

Associate Director, Global Clinical Operations, ILIAD Biotechnologies

Clinical Trial Manager, Scholar Rock

Sr. Director, Business Ops and Clinical Outsourcing, Kailera Therapeutics

Sr. Director, Global Clinical Research, iRhythm Technologies, Inc.

Vice President, PhaseWell Research

Alliance Manager, Pharmaron CPC, Inc.

Director, Clinical Operations, Cleveland Diagnostics

Clinical Research/Operations Project Manager, Cleveland Diagnostics, Inc.

Sr. Compliance Manager, Takeda

Clinical Trial Assistant, Cleveland Diagnostics

Clinical Research Coordinator, Womens Cancer Care Associates

Director, Process Excellence & Delivery, Takeda

Associate Director, Global Clinical Operations, Takeda Pharmaceuticals

FBW Clinical Intro

Where Trial Optimization, Quality and Innovation Meet

Accelerate study start-up, improve protocol design, and reduce costs with strategies that drive patient engagement, decentralized trials, and AI-powered innovation. Stay ahead of regulatory changes while fostering quality and collaboration to deliver therapies faster.

Fierce Biotech Week 2026
May 12-14th

Accelerating Trials and Enhancing Quality:

Strategies for early site engagement
Strategies for early site engagement
Innovative strategies for early site engagement that can drive patient recruitment and retention
Adoption and scaling of DCTs
Adoption and scaling of DCTs
Examine the industry conditions impacting the adoption and scaling of DCTs and the different models companies are using to reach more patients
Drive greater sponsor-CRO-site collaboration
Drive greater sponsor-CRO-site collaboration
Hear how to drive greater sponsor-CRO-site collaboration and communication, and the latest on oversight approaches for external stakeholders
Effective clinical quality oversight and risk-based approaches
Effective clinical quality oversight and risk-based approaches
Discuss effective clinical quality oversight strategies and risk-based approaches that ensure studies and vendors are compliant and inspection ready
Harnessing AI and Tech to Accelerate Trials and Expand Patient Reach
Harnessing AI and Tech to Accelerate Trials and Expand Patient Reach
Explore process innovations and technologies like AI and wearables that are reducing the trial cycle and connecting researchers to more patients

Key topics covered in the Clinical track:

  Study start-up and protocol design


  Site engagement and patient recruitment


  Clinical quality and GCP


  Decentralized and hybrid clinical trials


  Trial design and data governance


  Vendor Collaboration and oversight


  RBQM and monitoring


  Technology and innovation

FBW Clinical Topics